Kristen Ciombor, M.D., reflects on recent wins and opportunities ahead in the precision targeting of colorectal cancer.

Three-dimensional scanning and printing systems are now utilized for purposes ranging from same-day dental crowns to prosthetic limbs, so Michael Topf, MD, wondered why computer-aided design (CAD) technology hadn’t made it into operating rooms as a visual aid for real-time consultations.  Surgeons communicate via phone and are dependent upon verbal descriptions from pathologists for guidance […]

Vanderbilt researchers found that T cells become exhausted within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.

Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity.

Vanderbilt's Neil Osheroff, PhD, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years.

An international collaboration led by biochemist David Cortez reached revelatory conclusions in exploration of how cells tolerate DNA damage and genome instability. Est. reading time: 2 mins.

Vanderbilt Colorectal cancer expert Bob Coffey, MD, was recently invited to present his research to representatives of President Joe Biden’s reignited Cancer Moonshot initiative.